Michael R. Bristow
2014
In 2014, Michael R. Bristow earned a total compensation of $501.4K as President and Chief Executive Officer at ARCA biopharma.
Compensation breakdown
| Non-Equity Incentive Plan | $21,100 |
|---|---|
| Option Awards | $76,586 |
| Salary | $279,564 |
| Stock Awards | $110,565 |
| Other | $13,585 |
| Total | $501,400 |
Bristow received $279.6K in salary, accounting for 56% of the total pay in 2014.
Bristow also received $21.1K in non-equity incentive plan, $76.6K in option awards, $110.6K in stock awards and $13.6K in other compensation.
Rankings
In 2014, Michael R. Bristow's compensation ranked 10,259th out of 13,032 executives tracked by ExecPay. In other words, Bristow earned more than 21.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,259 out of 13,032 | 21st |
Division Manufacturing | 3,896 out of 4,965 | 22nd |
Major group Chemicals And Allied Products | 1,338 out of 1,690 | 21st |
Industry group Drugs | 1,071 out of 1,369 | 22nd |
Industry In Vitro and In Vivo Diagnostic Substances | 49 out of 72 | 32nd |
Source: SEC filing on April 27, 2016.
Bristow's colleagues
We found one more compensation record of an executive who worked with Michael R. Bristow at ARCA biopharma in 2014.
2014
Christopher Ozeroff
ARCA biopharma
General Counsel
News
ARCA biopharma CEO Michael Bristow's 2021 pay falls 50% to $527K
November 3, 2022
ARCA biopharma CEO Michael Bristow's 2020 pay jumps 258% to $1.1M
April 21, 2021
ARCA biopharma COO Thomas Keuer's 2019 pay slips 7% to $304K
October 28, 2020
ARCA biopharma COO Thomas Keuer's 2018 pay falls 29% to $327K
October 25, 2019